Literature DB >> 7923919

Experimental Chagas' disease: electrophysiology and cell composition of the neuromyopathic inflammatory lesions in mice infected with a myotropic and a pantropic strain of Trypanosoma cruzi.

G A Mirkin1, M Jones, O P Sanz, R Rey, R E Sica, S M González Cappa.   

Abstract

C3H/HeN mice infected with the pantropic/reticulotropic Trypanosoma cruzi RA strain disclosed electromyographic signs (EMG) of neuropathic damage, while those infected with the myotropic CA-I strain showed EMG suggestive of primary muscle involvement. Although both strains induced inflammatory infiltrates in hamstring muscles (HM), damage was more severe in mice infected with CA-I. In sciatic nerves (SN) of mice infected with the RA strain, increased inflammatory changes, amastigote nests, and myelin digestion chambers were consistently found during the course of infection. On the other hand, the CA-I strain produced minor inflammatory changes without detectable amastigotes in such tissue. The RA strain induced chronic leptomeningitis in spinal cord (SC), while infiltrates were limited to spinal roots and dorsal ganglia in animals infected with CA-I. In mice infected with RA, phenotypic analysis of inflammatory lesions showed a consistent predominance of CD8+ T cells in nervous tissue throughout the course of infection and in HM during the chronic phase whereas natural killer cells were detected at 120 and 270 days pi. In mice infected with CA-I, a predominance of CD8+ cells in SN was only detected during the acute phase and in HM during the late chronic phase; B lymphocytes bearing surface IgM were present in all studied tissues at 270 days pi. In addition, positive fluorescence for mouse IgG was observed at 120 days pi in muscle interstitium. These results strongly suggest that T. cruzi strain-dependent mechanisms are involved in the development of neuromyopathic damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923919     DOI: 10.1006/clin.1994.1171

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

1.  Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase.

Authors:  F S Buckner; A J Wilson; W C Van Voorhis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Involvement of nitric oxide synthase and protein kinase C activation on chagasic antibodies action upon cardiac contractility.

Authors:  L Sterin-Borda; G Cremaschi; A M Genaro; A V Echagüe; J C Goin; E Borda
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

3.  "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue.

Authors:  R L Tarleton; L Zhang; M O Downs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules.

Authors:  M G Grisotto; M R D'Império Lima; C R Marinho; C E Tadokoro; I A Abrahamsohn; J M Alvarez
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

5.  Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile.

Authors:  Julian Maggini; Gerardo Mirkin; Ianina Bognanni; Josefina Holmberg; Isabel M Piazzón; Irene Nepomnaschy; Héctor Costa; Cristian Cañones; Silvina Raiden; Mónica Vermeulen; Jorge R Geffner
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

6.  Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.

Authors:  Estela I Batalla; Agustina M Pino Martínez; Carolina V Poncini; Tomás Duffy; Alejandro G Schijman; Stella M González Cappa; Catalina D Alba Soto
Journal:  J Innate Immun       Date:  2013-05-08       Impact factor: 7.349

7.  Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.

Authors:  Ágata Carolina Cevey; Gerardo Ariel Mirkin; Federico Nicolás Penas; Nora Beatriz Goren
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-12-12       Impact factor: 4.077

8.  Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma cruzi-Infected Mice.

Authors:  Federico Nicolás Penas; Davide Carta; Ganna Dmytrenko; Gerado A Mirkin; Carlos Pablo Modenutti; Ágata Carolina Cevey; Maria Jimena Rada; Maria Grazia Ferlin; María Elena Sales; Nora Beatriz Goren
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

9.  Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.

Authors:  Ágata C Cevey; Gerardo A Mirkin; Martín Donato; María J Rada; Federico N Penas; Ricardo J Gelpi; Nora B Goren
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-07       Impact factor: 4.077

10.  Pyridinecarboxylic Acid Derivative Stimulates Pro-Angiogenic Mediators by PI3K/AKT/mTOR and Inhibits Reactive Nitrogen and Oxygen Species and NF-κB Activation Through a PPARγ-Dependent Pathway in T. cruzi-Infected Macrophages.

Authors:  Federico Nicolás Penas; Davide Carta; Ágata Carolina Cevey; María Jimena Rada; Azul Victoria Pieralisi; María Grazia Ferlin; María Elena Sales; Gerardo A Mirkin; Nora Beatriz Goren
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.